Showing 951-960 of 3016 results for "".
Antibiotics and Cosmetic Trends; Seysara Launches
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-antibiotics-and-cosmetics-trends-seysara-launches/19532/Dermatologists are prescribing fewer antibiotics to manage acne and rosacea. But, the use of antibiotics after surgical procedures is on the rise. More than one third of American adults are considering a cosmetic treatment in 2019, results of a RealSelf survey show. Seysara (sarecycline), a novel teSpirit Squad: How to Fix Broken Morale
https://practicaldermatology.com/topics/practice-management/spirit-squad-how-to-fix-broken-morale/20479/Manage low morale effectively before it hurts your practice.Counting on Success
https://practicaldermatology.com/topics/practice-management/counting-on-success/21049/Best practices for retail inventory management in the medical practice.Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.Journal Club: How Physicians Can Use the New AD Guidelines in Practice
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/how-physicians-can-use-the-new-ad-guidelines-in-practice/24094/In this second part of the inaugural edition of Practical Dermatology's® Atopic Dermatitis (AD) Journal Club, Derek Chu, MD, a key architect of new guidelines for AD management and care, talks with Peter Lio, MD, about his vision for how to make these guidelines easy-to-use and practical for dermatoSkin of Color Session: Dr. Harris
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/skin-of-color-session-dr-harris/32683/John E. Harris, MD, PhD, summarizes his vitiligo talk from the "Skin of Color Session" at Maui Derm 2025, during which he covered new therapeutic options for vitiligo as well as promising drugs in the pipeline and why they could be so impactful.How Air Pollution Affects the Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-air-pollution-affects-the-skin/24041/An Interview with Dr. Mark Birch-MachinStrength in Numbers: Assessing Your Financial Position
https://practicaldermatology.com/topics/practice-management/strength-in-numbers-assessing-your-financial-position/23863/Look at your ratios and ranges to make sure you are keeping up with industry—and economic—shifts.Clinical Conversations: Risks vs Benefits of JAK Inhibitors
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-risks-vs-benefits-of-jak-inhibitors/20108/Clinical data for JAK inhibitors show clear benefits for many patients. But these drugs are associated with certain risks and class warnings. Matt Zirwas, MD and Adelaide Hebert, MD describe how they weigh risks, educate patients, and optimize long-term management.Grow Your Practice Through Patient Retention
https://practicaldermatology.com/topics/practice-management/grow-your-practice-through-patient-retention/23567/Patients have many options when choosing where to go for aesthetic treaments. Learn strategies for turning your current patients into repeat customers.